Hexarelin
Hexarelin is a potent, synthetic hexapeptide and growth hormone secretagogue (GHS) that stimulates the release of growth hormone. Research indicates it is one of the strongest GH-releasing peptides available, offering potential benefits for muscle growth, fat loss, and cardiovascular health without significantly increasing appetite.
01Dosing reference
02Mechanism of action
Ghrelin Receptor Activation
Hexarelin binds to the growth hormone secretagogue receptor (GHSR1a) in the pituitary gland and hypothalamus.
Growth Hormone Release
This activation triggers a pulsatile release of growth hormone (GH) into the bloodstream, independent of the body's natural somatostatin levels.
Cardioprotective Action
Hexarelin also binds to CD36 receptors in cardiac tissue, which research suggests may protect heart cells from ischemic injury and improve cardiac function.
03Human evidence
Significant dose-dependent increase in growth hormone levels.
Clinical studies in healthy adults and children with GH deficiency showed Hexarelin strongly stimulates GH release, often more potently than GH-releasing hormone (GHRH).
Prolactin and cortisol elevation.
Human trials noted that Hexarelin administration transiently increases serum prolactin and cortisol levels, though typically within safe physiological ranges.
04Preclinical evidence
Protection against ischemic heart damage.
In rodent models of myocardial infarction, Hexarelin reduced infarct size and improved left ventricular function, likely via CD36 receptor binding.
Prevention of muscle wasting.
Animal studies demonstrate that Hexarelin can mitigate muscle atrophy induced by glucocorticoids or denervation, promoting muscle preservation.
05What is known vs. unknown
- Hexarelin is one of the most potent growth hormone-releasing peptides (GHRPs).
- Unlike GHRP-6, Hexarelin does not typically induce a strong hunger response.
- It has unique cardioprotective properties mediated through CD36 receptors.
- Prolonged use may lead to receptor desensitization, reducing its GH-releasing efficacy over time.
- The long-term safety and effects of chronic Hexarelin use in humans remain largely unstudied.
- The exact clinical relevance of its cardioprotective effects observed in animals needs further validation in human trials.
- Optimal cycling protocols to prevent receptor desensitization are based on anecdotal evidence rather than rigorous clinical data.
06Safety & regulatory context
07Compared with GHRP-6
08Glossary
09Knowledge check
10Sources
More in Growth Hormone
Sermorelin
Sermorelin is a synthetic peptide consisting of the first 29 amino acids of naturally occurring growth hormone-releasing hormone (GHRH). It stimulates the pituitary gland to naturally produce and release human growth hormone (hGH), making it a subject of research for age-related growth hormone decline, body composition, and vitality.
Tesamorelin
Tesamorelin is a synthetic analogue of growth hormone-releasing hormone (GHRH) that stimulates the pituitary gland to secrete growth hormone. It is FDA-approved for reducing excess visceral abdominal fat in HIV-infected patients with lipodystrophy and is being researched for potential cognitive benefits.
GHRP-6
GHRP-6 (Growth Hormone Releasing Peptide-6) is a synthetic hexapeptide that stimulates the release of endogenous growth hormone from the pituitary gland. Research shows it can increase appetite, promote muscle growth, and aid in fat loss by mimicking the action of ghrelin.